Skip to main content
Clinical Trials/NCT01242462
NCT01242462
Completed
Phase 1

Feasibility of Mid-frequency Ventilation in Newborn Infants With Respiratory Distress Syndrome (RDS): Crossover Pilot Trial

University of Alabama at Birmingham1 site in 1 country12 target enrollmentOctober 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Respiratory Distress Syndrome, Newborn
Sponsor
University of Alabama at Birmingham
Enrollment
12
Locations
1
Primary Endpoint
Average delta pressure
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Respiratory distress syndrome (RDS) is the most common respiratory disorder in preterm infants. Despite improved survival of extremely premature infants with RDS, complications related to mechanical ventilation still occur. This trial will attempt to maintain adequate gas exchange at a rapid rate, short inspiratory time, low tidal volume, and low peak inspiratory pressure in infants with respiratory distress requiring mechanical ventilation. A cross over design will be used to test the hypothesis whether mid-frequency ventilation in preterm infants with RDS requiring mechanical ventilation will reduce the peak inspiratory pressure requirement when compared to conventional mechanical ventilation.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
May 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ramachandra Bhat, MD

Fellow Instructor, Department of Pediatrics, Division of Neonatology

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Inborn newborn infants with birthweight greater than or equal to 500gms, with gestational age greater than or equal to 24 weeks but less than or equal to 36 weeks.
  • Postnatal age less than or equal to 7 days.
  • Infant with respiratory distress syndrome (RDS) on mechanical ventilation with less than or equal to 60 breaths/minute, initially requiring greater than or equal to 30% FiO
  • Written informed consent.

Exclusion Criteria

  • Blood culture positive sepsis, life threatening congenital anomalies, cyanotic congenital heart diseases, hydrops fetalis, outborn infants, non viability as determined by the attending physician, and newborns who are considered too unstable for study enrollment as per neonatology attending/fellow.

Outcomes

Primary Outcomes

Average delta pressure

Time Frame: 4 hours

Difference in peak inspiratory pressure (PIP) and peak end expiratory pressure (PEEP) (average delta pressure) during two time periods--time period on conventional synchronized intermittent ventilation (SIMV) and time period on mid-frequency ventilation, randomly assigned.

Secondary Outcomes

  • Average Mean Airway Pressure (MAP)(Less than 4 hours)
  • Mean arterial pressure(Less than 4 hours)
  • Average delta pressure(Less than 4 hours)

Study Sites (1)

Loading locations...

Similar Trials